Skip to content
★ Sign in to follow
熊

熊英

Executive
Chief Executive Officer
九典制药美农生物
Insider activity · 24 months0 buys4 salesCumulative net flow
Total declarations
4
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€1.2M

Latest filing published 16 Sept 2025 for 美农生物, €400k.

Filing timeline

BuySale
熊英

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

熊英: trading record in brief

This profile gathers the share dealings of 熊英 across 2 companies, led by 美农生物 and 九典制药. Over a trading history stretching from 27 June 2025 to 16 September 2025, the count stands at 4 filings.

On the market, this insider has only sold: 4 sales, €1.2M in total.

The record was last updated on 16 September 2025 with an open-market sale (€400k) in 美农生物. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Companies and markets linked to 熊英

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▼
    董事,高管Executives美农生物
    3M CNY12SZSE
    183,000 shares48.2% of flowA股XSHESZSE:173000009546599580
  • ▼
    董事,高管Executives美农生物
    2M CNY10SZSE
    110,000 shares30.1% of flowA股XSHESZSE:173000009508741600
  • ▼
    董事,高管Executives美农生物
    1M CNY9SZSE
    80,000 shares21.7% of flowA股XSHESZSE:173000009503254560
  • ▼
    高管Executives九典制药
    3M CNY19SZSE
    179,700 shares100.0% of flowA股XSHESZSE:173000009149892200

4 of 4 declarations